Literature DB >> 19508169

Hepatitis C virus infection and the risk of coronary disease.

Adeel A Butt1, Wang Xiaoqiang, Matthew Budoff, David Leaf, Lewis H Kuller, Amy C Justice.   

Abstract

BACKGROUND: The association between hepatitis C virus (HCV) infection and coronary artery disease (CAD) is controversial. We conducted this study to determine and quantify this association.
METHODS: We used an established, national, observational cohort of all HCV-infected veterans receiving care at all Veterans Affairs facilities, the Electronically Retrieved Cohort of HCV Infected Veterans, to identify HCV-infected subjects and HCV-uninfected control subjects. We used the Cox proportional-hazards model to determine the risk of CAD among HCV-infected subjects and control subjects.
RESULTS: We identified 82,083 HCV-infected and 89,582 HCV-uninfected subjects. HCV-infected subjects were less likely to have hypertension, hyperlipidemia, and diabetes but were more likely to abuse alcohol and drugs and to have renal failure and anemia. HCV-infected subjects had lower mean (+/- standard deviation) total plasma cholesterol (175 +/- 40.8 mg/dL vs. 198 +/- 41.0 mg/dL), low-density lipoprotein cholesterol (102 +/- 36.8 mg/dL vs. 119 +/- 38.2 mg/dL), and triglyceride (144 +/- 119 mg/dL vs. 179 +/- 151 mg/dL) levels, compared with HCV-uninfected subjects (P < .001 for all comparisons). In multivariable analysis, HCV infection was associated with a higher risk of CAD (hazard ratio, 1.25; 95% confidence interval, 1.20-1.30). Traditional risk factors (age, hypertension, chronic obstructive pulmonary disease, diabetes, and hyperlipidemia) were associated with a higher risk of CAD in both groups, whereas minority race and female sex were associated with a lower risk of CAD.
CONCLUSIONS: HCV-infected persons are younger and have lower lipid levels and a lower prevalence of hypertension. Despite a favorable risk profile, HCV infection is associated with a higher risk of CAD after adjustment for traditional risk factors.

Entities:  

Mesh:

Year:  2009        PMID: 19508169      PMCID: PMC3077953          DOI: 10.1086/599371

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  43 in total

1.  Hepatitis C virus and atherosclerosis in patients with type 2 diabetes.

Authors:  Michiaki Fukui; Yoshihiro Kitagawa; Naoto Nakamura; Toshikazu Yoshikawa
Journal:  JAMA       Date:  2003-03-12       Impact factor: 56.272

2.  Evidence for association between hepatitis C virus seropositivity and coronary artery disease.

Authors:  C Vassalle; S Masini; F Bianchi; G C Zucchelli
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

3.  Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening.

Authors:  Nobukazu Ishizaka; Yuko Ishizaka; Eiko Takahashi; Ei ichi Tooda; Hideki Hashimoto; Ryozo Nagai; Minoru Yamakado
Journal:  Lancet       Date:  2002-01-12       Impact factor: 79.321

4.  Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.

Authors:  Arun J Sanyal; Melissa J Contos; Richard K Sterling; Velimir A Luketic; Mitchell L Shiffman; R Todd Stravitz; A Scott Mills
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

5.  Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.

Authors:  Samuel A Bozzette; Christopher F Ake; Henry K Tam; Sophia W Chang; Thomas A Louis
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

6.  Hepatitis B and C virus infection and the risk of atherosclerosis in a general population.

Authors:  Henry Völzke; Christian Schwahn; Birger Wolff; Renate Mentel; Daniel M Robinson; Volker Kleine; Stephan B Felix; Ulrich John
Journal:  Atherosclerosis       Date:  2004-05       Impact factor: 5.162

Review 7.  Inflammatory reactions in the pathogenesis of atherosclerosis.

Authors:  Jianglin Fan; Teruo Watanabe
Journal:  J Atheroscler Thromb       Date:  2003       Impact factor: 4.928

Review 8.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

9.  Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection.

Authors:  Adeel A Butt; Shawn L Fultz; C Kent Kwoh; David Kelley; Melissa Skanderson; Amy C Justice
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

10.  Comparison of two VA laboratory data repositories indicates that missing data vary despite originating from the same source.

Authors:  Kathleen A McGinnis; Melissa Skanderson; Forrest L Levin; Cynthia Brandt; Joseph Erdos; Amy C Justice
Journal:  Med Care       Date:  2009-01       Impact factor: 2.983

View more
  112 in total

1.  Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease.

Authors:  Adeel A Butt; Chung-Chou Chang; Lewis Kuller; Matthew Bidwell Goetz; David Leaf; David Rimland; Cynthia L Gibert; Krisann K Oursler; Maria C Rodriguez-Barradas; Joseph Lim; Lewis E Kazis; Stephen Gottlieb; Amy C Justice; Matthew S Freiberg
Journal:  Arch Intern Med       Date:  2011-04-25

2.  Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study.

Authors:  K A Forde; K Haynes; A B Troxel; S Trooskin; M T Osterman; S E Kimmel; J D Lewis; V Lo Re
Journal:  J Viral Hepat       Date:  2011-11-13       Impact factor: 3.728

Review 3.  The epidemiology of substance use disorders in US Veterans: A systematic review and analysis of assessment methods.

Authors:  Chiao-Wen Lan; David A Fiellin; Declan T Barry; Kendall J Bryant; Adam J Gordon; E Jennifer Edelman; Julie R Gaither; Stephen A Maisto; Brandon D L Marshall
Journal:  Am J Addict       Date:  2015-12-22

4.  The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection.

Authors:  Parag Mahale; Eric A Engels; Ruosha Li; Harrys A Torres; Lu-Yu Hwang; Eric L Brown; Jennifer R Kramer
Journal:  Gut       Date:  2017-06-20       Impact factor: 23.059

Review 5.  Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.

Authors:  Umberto Vespasiani-Gentilucci; Paolo Gallo; Antonio De Vincentis; Giovanni Galati; Antonio Picardi
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

Review 6.  Assessing cardiovascular risk in hepatitis C: An unmet need.

Authors:  Javier Ampuero; Manuel Romero-Gómez
Journal:  World J Hepatol       Date:  2015-09-08

7.  Liver fibrosis progression in hepatitis C virus infection after seroconversion.

Authors:  Adeel A Butt; Peng Yan; Vincent Lo Re; David Rimland; Matthew B Goetz; David Leaf; Matthew S Freiberg; Marina B Klein; Amy C Justice; Kenneth E Sherman
Journal:  JAMA Intern Med       Date:  2015-02       Impact factor: 21.873

8.  Association of hepatitis C with markers of hemostasis in HIV-infected and uninfected women in the women's interagency HIV study (WIHS).

Authors:  Elizabeth M Kiefer; Qiuhu Shi; Donald R Hoover; Robert Kaplan; Russell Tracy; Michael Augenbraun; Chenglong Liu; Marek Nowicki; Phyllis C Tien; Mardge Cohen; Elizabeth T Golub; Kathryn Anastos
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

9.  Hypertension in long-term survivors of pediatric hematopoietic cell transplantation.

Authors:  Paul A Hoffmeister; Sangeeta R Hingorani; Barry E Storer; K Scott Baker; Jean E Sanders
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-02       Impact factor: 5.742

10.  Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population.

Authors:  L Kakinami; R C Block; M J Adams; S E Cohn; B Maliakkal; S G Fisher
Journal:  Int J Clin Pract       Date:  2013-01       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.